Literature DB >> 35607536

Recurrence Yield of Stereotactic Biopsy of Suspicious Calcifications After Breast Conservation Therapy.

Javaria Aleem1, Sara Rehman1, Mehreen Shafqat1, Hamd Zahra1, Javeria Ashraf1, Imran Khalid Niazi2.   

Abstract

Aim To analyze the histopathological outcome of stereotactic biopsies of newly developed suspicious calcifications at lumpectomy scar site in patients with breast conservation surgery (BCS) to determine the incidence of malignancy and the association of mammographic appearance of recurrent microcalcification and their distribution. We also determined the association of disease recurrence with the presence of calcifications in original tumor and lumpectomy resection margins with the risk of recurrence. Materials and methods This study is a retrospective review of mammograms of patients with breast cancer from 2010 to 2021 who underwent stereotactic biopsy of newly developed suspicious calcifications at scar site appreciated on annual follow-up mammogram after breast conservation surgery (BCS) with no mass on correlative ultrasound. The radiological and pathological features of the patients' primary tumor and new calcifications were obtained from the hospital's electronic patient record system. Results A total of 84 patients with breast cancer developed suspicious microcalcifications at the lumpectomy scar site detected on follow-up mammograms after BCS, and 28.6% showed malignant histopathological outcomes. All malignant cases demonstrated pleomorphic morphology. All amorphous (9.5%) and coarse heterogeneous (54.8%) calcifications were benign. The distribution pattern of recurrent malignant calcifications was grouped in 9.5%, regional in 2.4%, linear in 9.5%, and segmental in 7.1%. Calcifications in primary tumors were found in 20.2% of cases. Positive margins were found in 7.1% of these malignant cases. Statistically, there was a strong association between calcification morphology, calcification distribution, presence of calcifications on baseline mammogram, and tumor resection margins. The presence of calcifications in primary tumors and positive resection margins were identified as significant independent risk factors of malignant recurrent calcifications in the logistic regression model and marginal statistical significance in the multivariable logistic regression (MLR) model. Conclusion The interval development of pleomorphic calcifications after BCS with either linear or segmental pattern, positive resection margins, and associated calcifications in primary tumors was related to the increase in the risk of recurrence. Although amorphous and coarse heterogeneous morphology with grouped distribution showed benign outcomes, stereotactic biopsy is recommended to exclude disease recurrence in this high-risk patient population.
Copyright © 2022, Aleem et al.

Entities:  

Keywords:  breast cancer; breast conservation surgery; mammogram; microcalcifications; recurrence; stereotactic core biopsy; suspicious calcifications; tumor resection margins

Year:  2022        PMID: 35607536      PMCID: PMC9123400          DOI: 10.7759/cureus.24318

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

Review 1.  BI-RADS Terminology for Mammography Reports: What Residents Need to Know.

Authors:  Karina Pesce; María B Orruma; Carolina Hadad; Yesenia Bermúdez Cano; Roberto Secco; Andrea Cernadas
Journal:  Radiographics       Date:  2019 Mar-Apr       Impact factor: 5.333

Review 2.  A Pictorial Review of Changes in the BI-RADS Fifth Edition.

Authors:  Ajay Aroor Rao; Jennifer Feneis; Chloe Lalonde; Haydee Ojeda-Fournier
Journal:  Radiographics       Date:  2016-04-15       Impact factor: 5.333

Review 3.  Imaging the post-surgical breast.

Authors:  E B Mendelson
Journal:  Semin Ultrasound CT MR       Date:  1989-04       Impact factor: 1.875

4.  Breast conservation therapy versus mastectomy for breast cancer.

Authors:  Alastair M Thompson
Journal:  Lancet Oncol       Date:  2020-04       Impact factor: 41.316

5.  Management of microcalcifications developing at the lumpectomy bed after conservative surgery and radiation therapy.

Authors:  Işil Günhan-Bilgen; Ayşenur Oktay
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

6.  Patterns of mammographically detected calcifications after breast-conserving therapy associated with tumor recurrence.

Authors:  D D Dershaw; C S Giess; B McCormick; P Borgen; L Liberman; A F Abramson; E Morris
Journal:  Cancer       Date:  1997-04-01       Impact factor: 6.860

7.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

8.  Breast-Conserving Therapy is Associated with Improved Survival Compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database.

Authors:  Erica Wrubel; Raylene Natwick; G Paul Wright
Journal:  Ann Surg Oncol       Date:  2020-07-13       Impact factor: 5.344

9.  Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases.

Authors:  Stefanie Corradini; Daniel Reitz; Montserrat Pazos; Stephan Schönecker; Michael Braun; Nadia Harbeck; Christiane Matuschek; Edwin Bölke; Ute Ganswindt; Filippo Alongi; Maximilian Niyazi; Claus Belka
Journal:  Cancers (Basel)       Date:  2019-01-31       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.